Mouse model characterisation for anthrax vaccine development: comparison of one inbred and one outbred mouse strain.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Microbial Pathogenesis

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.MICPATH.2004.10.007PMID 15652293
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine.

  2004cited by this paper
• Development of an in vitro-based potency assay for anthrax vaccine.

  2004cited by this paper
• Differential Processing of CD4 T-cell Epitopes from the Protective Antigen of Bacillus anthracis*

  2003cited by this paper
• A Recombinant Carboxy-Terminal Domain of the Protective Antigen of Bacillus anthracis Protects Mice against Anthrax Infection

  2002cited by this paper
• In vitro correlate of immunity in a rabbit model of inhalational anthrax.

  2001cited by this paper
• Passive transfer of protection against Bacillus anthracis infection in a murine model.

  2001cited by this paper
• Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin.

  2001cited by this paper
• Medical Statistics at a Glance

  2000cited by this paper
• Comparison and Characterization of Immunoglobulin G Subclasses among Primate Species

  1999cited by this paper
• Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax.

  1999cited by this paper
• Presentation of protective antigen to the mouse immune system: immune sequelae

  1999cited by this paper
• Low antigen dose favours selection of somatic mutants with hallmarks of antibody affinity maturation

  1998cited by this paper
• Protective efficacy of a recombinant protective antigen against Bacillus anthracis challenge and assessment of immunological markers.

  1998cited by this paper
• Production and purification of recombinant protective antigen and protective efficacy against Bacillusanthracis

  1998cited by this paper
• Nonhuman primate models to evaluate vaccine safety and immunogenicity.

  1997cited by this paper
• Crystal structure of the anthrax toxin protective antigen

  1997cited by this paper
• Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques.

  1996cited by this paper
• Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants

  1992cited by this paper
• Serum protease cleavage of Bacillus anthracis protective antigen.

  1992cited by this paper
• Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in mice.

  1988cited by this paper
• Differences in susceptibility of inbred mice to Bacillus anthracis

  1986cited by this paper
• Demonstration of a capsule plasmid in Bacillus anthracis

  1985cited by this paper
• Immunoelectrophoretic analysis, toxicity, and kinetics of in vitro production of the protective antigen and lethal factor components of Bacillus anthracis toxin

  1984cited by this paper
• Evidence for plasmid-mediated toxin production in Bacillus anthracis

  1983cited by this paper
• Primer of biostatistics : statistical software program version 6.0

  1981cited by this paper
• The collison nebulizer: Description, performance and application

  1973cited by this paper
• An apparatus for the study of airborne infection

  1952cited by this paper

• Identification of Potential Therapeutic Targets Against Anthrax-Toxin-Induced Liver and Heart Damage

  2025cites this paper
• A multipathogen DNA vaccine elicits protective immune responses against two class A bioterrorism agents, anthrax and botulism

  2022cites this paper
• Long-Lasting Protection Induced by a Polyanhydride Nanovaccine against Respiratory Syncytial Virus in an Outbred Mouse Model

  2022cites this paper
• Use of protective antigen of Bacillus anthracis as a model recombinant antigen to evaluate toll-like receptors 2, 3, 4, 7 and 9 agonists in mice using established functional antibody assays, antigen-specific antibody assays and cellular assays.

  2022cites this paper
• Evaluation of an outbred mouse model for Francisella tularensis vaccine development and testing

  2018cites this paper
• Manipulation of antigen presenting cells to enhance host immune responses to bacterial infection

  2015cites this paper
• Animal Models for the Pathogenesis, Treatment, and Prevention of Infection by Bacillus anthracis

  2015cites this paper
• Bacillus anthracis and Other Bacillus Species

  2015cites this paper
• Approaches to Modelling the Human Immune Response in Transition of Candidates from Research to Development

  2014cites this paper
• Specific Activation of Dendritic Cells Enhances Clearance of Bacillus anthracis following Infection

  2014cites this paper
• A Single-Dose PLGA Encapsulated Protective Antigen Domain 4 Nanoformulation Protects Mice against Bacillus anthracis Spore Challenge

  2013cites this paper
• Immunization of Mice with Formalin-Inactivated Spores from Avirulent Bacillus cereus Strains Provides Significant Protection from Challenge with Bacillus anthracis Ames

  2012cites this paper
• Characterization of a multi-component anthrax vaccine designed to target the initial stages of infection as well as toxaemia.

  2012cites this paper
• Serodiagnosis of Human Cutaneous Anthrax in India Using an Indirect Anti-Lethal Factor IgG Enzyme-Linked Immunosorbent Assay

  2012cites this paper
• Characterization of New and Advancement of Existing Animal Models of Bacillus anthracis Infection

  2012cites this paper
• The early humoral immune response to Bacillus anthracis toxins in patients infected with cutaneous anthrax.

  2011cites this paper
• Post-exposure therapy of inhalational anthrax in the common marmoset.

  2011cites this paper
• [Recombinant antibodies for medical protection against bioterrorism agents: the example of anthrax].

  2010cites this paper
• Influence of particle size on the pathology and efficacy of vaccination in a murine model of inhalational anthrax.

  2010cites this paper
• The Major Neutralizing Antibody Responses to Recombinant Anthrax Lethal and Edema Factors Are Directed to Non-Cross-Reactive Epitopes

  2009cites this paper
• Efficacy of a Vaccine Based on Protective Antigen and Killed Spores against Experimental Inhalational Anthrax (cid:1) ‡

  2009influential citation
• DNA vaccines for biodefense

  2009cites this paper
• Mouse Models of Influenza

  2009cites this paper
• A novel immunogenic spore coat-associated protein in Bacillus anthracis: characterization via proteomics approaches and a vector-based vaccine system.

  2008cites this paper
• Role of Anthrax Toxins in Dissemination, Disease Progression, and Induction of Protective Adaptive Immunity in the Mouse Aerosol Challenge Model

  2008cites this paper
• A DNA vaccine candidate for B. anthracis immunization, pcDNA3.1+PA plasmid, induce Th1/Th2 mixed responses and protection in mice

  2008cites this paper
• A Study of PA DNA/Dendron Nanoparticles for Genetic Immunisation Against Anthrax

  2008cites this paper
• Analysis of epitope information related to Bacillus anthracis and Clostridium botulinum

  2008cites this paper
• Sequential B-Cell Epitopes of Bacillus anthracis Lethal Factor Bind Lethal Toxin-Neutralizing Antibodies

  2008cites this paper
• Experimental respiratory anthrax infection in the common marmoset (Callithrix jacchus)

  2008cites this paper
• Efficacy of a Vaccine Based on Protective Antigen and Killed Spores against Experimental Inhalational Anthrax

  2008influential citation
• Immunogenicity of Bacillus anthracis Protective Antigen Domains and Efficacy of Elicited Antibody Responses Depend on Host Genetic Background

  2008cites this paper
• Immunization against anthrax using Bacillus subtilis spores expressing the anthrax protective antigen.

  2007cites this paper
• Aluminum adjuvant linked to gulf war illness induces motor neuron death in mice

  2007cites this paper
• Behavioural and neurotoxic effects of aluminum hydroxide and squalene adjuvants in relation to amyotrophic lateral sclerosis-gulf war illness

  2006cites this paper
• ALUMINUM ADJUVANT LINKED TO GULF WAR SYNDROME INDUCES MOTOR NEURON DEATH IN MICE

  2006cites this paper
• Transcriptional analysis of protective antigen-stimulated PBMC from non-human primates vaccinated with the anthrax vaccine absorbed.

  2006cites this paper
• 3 Scientific and Ethical Importance of Animal Models in Biodefense Research

  2005cites this paper
• Immunization of Mice with Formalin-inactivated Spores from Avirulent Bacillus Cereus Strains Provides Significant Protection from Challenge with Bacillus Anthracis Ames "immunization of Mice with Formalin-inactivated Spores from Avirulent Bacillus Cereus Strains Provides Significant Protection from

  year unknowncites this paper